Oncology & Cancer

USPSTF: Offer breast CA risk-reducing Rx to high-risk patients

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends that women at increased risk of breast cancer be prescribed tamoxifen or raloxifene for risk reduction, according to a final Recommendation Statement ...

page 8 from 14